1. The recommended dose of a commercial competitive exclusion (CE) product (BROILACT) was given orally to newly-hatched broiler chicks to protect them against oral challenge by Salmonella enteritidis PT4. 2. In 5 replicate trials, half of the birds thus treated and half from untreated control groups were examined for salmonellas at 5 d and the other half at 12 d after challenge. 3. Caecal contents were examined quantitatively while heart, liver and spleen samples were examined qualitatively by enrichment. 4. The treatment effectively prevented both colonisation of the caeca and invasion of the other organs by S. enteritidis PT4; the average number of salmonellas was less than 10 colony forming units (cfu)/g of caecal contents in the treated birds and more than 10 million cfu/g in the untreated birds. 5. Infection of organs other than the caeca was completely prevented by protective treatment, whereas 38% of the untreated birds were still infected at the end of the trial.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/00071669208417519 | DOI Listing |
Vet Med Sci
January 2025
Department of Animal Nutrition and Nutritional Disease, Faculty of Veterinary Medicine, Burdur Mehmet Akif Ersoy University, Burdur, Turkey.
Photodynamic inactivation (PDI) is a new and promising strategy for eliminating foodborne pathogenic bacteria in food preservation, reducing associated health risks for consumers. This study aimed to develop an innovative PDI-based system to inactivate Salmonella Enteritidis PT4 on eggshells. The system includes 405 nm light-emitting diodes (LEDs) and the application of curcumin or carvacrol as photosensitizers.
View Article and Find Full Text PDFAccess Microbiol
November 2024
Departamento de Microbiologia, Universidade Federal de Viçosa (UFV), Av. Peter Henry Rolfs, Viçosa, 36570-900, Minas Gerais, Brazil.
Vet Res Commun
November 2024
Division of Biochemistry, Department of Physiology and Biochemistry, University of Veterinary Medicine, István utca 2, Budapest, H-1078, Hungary.
In this study, we observed the effect of the newly isolated probiotic strain Limosilactobacillus reuteri B1/1 on the relative gene expression of selected cytokines (interleukin-15, transforming growth factor-β4), tight junction proteins (E-cadherin, occludin), biomarker active intestinal stem cells - LGR5 (leucine-rich repeat containing G protein-coupled receptor), markers of mucosal intestinal immunity (mucin-2, immunoglobulin A), as well as the creation of a new biomarker of inflammation in the intestine - calprotectin on an ex vivo model of chicken ileal explant in the prevention of Salmonella Enteritidis PT4 infection. The ability of L. reuteri B1/1 to effectively modulate the mucosal immune response under pretreatment conditions in S.
View Article and Find Full Text PDFCurr Pharm Des
October 2024
Department of Bioinformatics and Biotechnology, Government College University Faisalabad (GCUF), Faisalabad, Pakistan.
Introduction: serovar Enteritidis and serovar Typhimurium are among the main causative agents of nontyphoidal Salmonella infections, imposing a significant global health burden. The emergence of antibiotic resistance in these pathogens underscores the need for innovative therapeutic strategies.
Objective: To identify proteins as potential drug targets against and Salmonella Typhimurium serovars using approaches.
Braz J Microbiol
December 2022
Department of Microbiology, Universidade Federal de Viçosa (UFV), Viçosa, MG, Brazil.
Salmonella is an important foodborne pathogen, and it is unable to produce the quorum sensing signaling molecules called acyl-homoserine lactones (AHLs). However, it synthesizes the SdiA protein, detecting AHL molecules, also known as autoinducer-1 (AI-1), in the external environment. Exogenous AHLs can regulate specific genes related to virulence and stress response in Salmonella.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!